Physician

Charles Joseph Bennett, M.D.

According to 2025 Medicare claims, Charles Bennett, M.D. (NPI: 1639127095) practices radiation oncology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is NORMAN H. ANDERSON, MD, PA (NPI: 1912955139; TIN: 591901972) and primary practice location at 34461-8547.

Bennett's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 635 traditional Medicare patients, billed 9,666 HCPCS/CPT codes, and received $1,403,861 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 1,241 prescription claims across 271 beneficiaries totaling $111,341 in drug costs, led by Tamoxifen Citrate (Tamoxifen Citrate). DME data shows 15 claims. Open Payments data shows 17 records totaling $474. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,190,478 to $1,403,861. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $60,058 and ending at $111,341. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $10,116 to $1,296.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	599	16,354	$2,190,478
2016	992	13,373	$1,673,458
2017	996	15,764	$1,998,138
2018	961	13,324	$1,750,794
2019	877	14,317	$1,922,720
2020	720	9,665	$1,215,772
2021	664	9,659	$1,313,742
2022	650	8,750	$1,168,597
2023	653	9,685	$1,186,256
2024	635	9,666	$1,403,861

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	272	1,328	$60,058
2016	272	1,477	$61,286
2017	326	1,639	$65,648
2018	327	1,379	$75,390
2019	364	1,424	$80,693
2020	334	1,489	$87,687
2021	268	1,159	$52,104
2022	281	1,228	$45,266
2023	277	1,208	$128,566
2024	271	1,241	$111,341

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	136	$9,875
2016	18	121	$7,155
2017	17	125	$6,122
2018	14	95	$4,125
2019	15	82	$5,944
2020	11	90	$7,318
2021	N/R	36	$3,306
2022	27	29	$6,414
2023	16	18	$3,735
2024	13	15	$3,004

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	174	733	$160
77263	Complex radiation therapy planning	120	131	$141
77334	Design and construction of complex radiation treatment device	127	300	$101
77336	Continuing radiation therapy consultation per week	190	713	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	409	695	$70

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamoxifen Citrate	Tamoxifen Citrate	75	6,540	$2,945
Fentanyl	Fentanyl	25	750	$2,472
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	1,935	$1,929
Anastrozole	Anastrozole	85	7,644	$1,700
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	1,448	$1,652

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	13	15	$3,004

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$474	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Joseph Bennett, M.D.?

Tedicare shows public-source Medicare data for Charles Joseph Bennett, M.D. (NPI 1639127095), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Joseph Bennett, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles Joseph Bennett, M.D.?

Charles Joseph Bennett, M.D. is linked to NORMAN H. ANDERSON, MD, PA (billing NPI 1912955139) in the available physician profile data.

Does Charles Joseph Bennett, M.D. have Open Payments data?

Charles Joseph Bennett, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.